Cultivated Meat Approval Law.

1. Introduction

Cultivated meat approval law refers to the legal framework governing the development, safety assessment, regulatory authorisation, manufacture, labelling, importation and sale of meat produced by growing animal cells in a controlled environment rather than raising and slaughtering an animal for its meat.

Cultivated meat is also known as cell-cultured meat, cell-based meat, or lab-grown meat. It is biologically derived from animal cells and is different from plant-based meat substitutes.

The principal legal question is whether a novel food produced using cellular agriculture can be lawfully marketed without satisfying the applicable pre-market safety, manufacturing, inspection and labelling requirements.

‘It’s not science fiction’: New East Bay facility producing lab-grown meat plans to produce 400,000 pounds per year

 

 

USDA approves cultivated chicken for consumers | News | New Food

 

 

 

8

 

The regulatory framework must balance several competing interests:

Public health: Preventing contamination, toxicity and allergic reactions.

Consumer protection: Ensuring accurate ingredient, production-method and product-origin disclosures.

Innovation: Allowing scientific developments to reach the market through predictable approval procedures.

Environmental protection: Assessing relevant production and waste-management risks.

Agricultural interests: Addressing effects on conventional livestock producers and food supply chains.

Administrative accountability: Ensuring that regulators make evidence-based, legally authorised decisions.

There is no single worldwide approval system. The United States, Singapore, the European Union, the United Kingdom, Australia and New Zealand use different regulatory routes. India requires a separate analysis under its existing food-safety legislation.

2. Meaning and scientific production process

Cultivated meat production generally involves the following stages.

Stage 1 — Cell collection

Cells are obtained from an animal and selected for their ability to grow under controlled conditions.

Stage 2 — Cell banking

Cell lines are screened, characterised and stored to support consistent production.

Stage 3 — Cell growth and differentiation

Cells multiply in a controlled growth medium containing nutrients and other necessary components.

Stage 4 — Harvesting and processing

The cells are harvested, processed and formulated into food products, followed by applicable quality and safety controls.

Stage 5 — Regulatory approval and sale

The manufacturer completes the required safety review, establishment approvals, inspections and labelling procedures before marketing.

The regulatory significance of these stages is that risks can arise not only from the final meat but also from the cell line, growth medium, processing inputs, manufacturing environment and changes to the production method. The US Food and Drug Administration (FDA) expressly considers these matters in its cultivated-animal-cell food review.

FDA

 

3. Legal framework for cultivated meat approval

A cultivated-meat manufacturer may need to satisfy several distinct legal requirements.

Legal requirementPrincipal issue
Product classificationWhether the product is a novel food, regulated meat, seafood or another category
Pre-market authorisationWhether prior regulatory clearance is mandatory
Safety assessmentToxicity, allergenicity, contamination, composition and dietary exposure
Manufacturing complianceFacility hygiene, process validation, traceability and quality controls
Labelling approvalProduct name, ingredients, allergen disclosures and permissible claims
Import authorisationWhether foreign approvals and local import requirements are satisfied
Post-market monitoringComplaints, adverse effects, recalls and continuing compliance

An approval in one country does not automatically authorise sale in another. The manufacturer must satisfy the law of each target market.

4. Cultivated meat approval law in India

India is particularly important because cultivated meat falls within a regulatory environment that already governs food safety, novel food products, ingredients, manufacturing and consumer labelling.

A. Principal legislation

1. Food Safety and Standards Act, 2006

The Food Safety and Standards Authority of India (FSSAI) administers the national food-safety framework. The Act establishes controls over food manufacture, processing, distribution, sale and importation.

Relevant provisions include:

Section 22: Regulates novel foods and specified categories of food products, including certain products involving novel technologies, subject to the applicable statutory framework.

Section 23: Governs packaging and labelling requirements.

Section 26: Places responsibilities on food business operators to ensure compliance with the Act and its rules and regulations.

Section 31: Establishes licensing and registration requirements for food businesses.

Sections 48–51: Address offences involving unsafe food, substandard food, misbranding and misleading representations, respectively, under the relevant provisions.

The precise provision applicable to a cultivated-meat product depends on its classification, composition and manufacturing process.

2. Food Safety and Standards (Approval for Non-Specified Food and Food Ingredients) Regulations, 2017

These regulations provide an approval route for food products and ingredients that are not adequately covered by existing standards, including relevant novel foods and products made using novel technologies.

FSSAI describes a process involving an application, supporting documentation and scientific risk analysis before approval.

FSSAI+1

 

3. Food Safety and Standards (Food Products Standards and Food Additives) Regulations, 2011

These regulations establish food-product standards and controls on additives. Their applicability must be examined alongside the non-specified-food approval requirements.

4. Food Safety and Standards (Packaging and Labelling) Regulations, 2011

The applicable packaging and labelling rules must be assessed for product identity, ingredient declarations and other required information. The current regulations and amendments should be checked before preparing a commercial label.

FSSAI

 

B. Is cultivated meat approved for commercial sale in India?

The important distinction is between the existence of a regulatory pathway and approval of a particular product.

The available industry-specific information from GFI India reports that FSSAI had not received an application for cultivated-meat product approval at the time of its published account, although it had examined possible regulatory pathways. This is not sufficient to establish the status of every application as of November 2026.

GFI India

 

Accordingly, a business should not assume that cultivated meat is automatically authorised for sale in India merely because the 2017 regulations provide a possible route for novel foods.

A prudent applicant would:

Consult FSSAI on the appropriate classification and approval route.

Prepare a detailed product dossier, including cell-line characteristics and the complete manufacturing process.

Submit evidence addressing toxicity, allergenicity, microbiological hazards, composition and dietary exposure.

Explain the safety of the growth medium, processing aids and other production inputs.

Demonstrate manufacturing consistency, hygiene, traceability and quality controls.

Obtain the required authorisations before commercial manufacture, importation or sale.

Comply with applicable licensing, packaging, labelling, advertising and post-market obligations.

The legal outcome depends on the product and the applicable regulations; scientific research or an informal consultation is not equivalent to regulatory approval.

5. Comparative international regulatory frameworks

USDA approves Upside Foods, Good Meat to sell cultivated chicken

 

 

A. United States

The FDA supervises cell collection, cell banking, growth and differentiation for covered cultivated-meat products. Oversight transfers to the US Department of Agriculture's Food Safety and Inspection Service (USDA-FSIS) at harvesting, followed by applicable inspection, processing and labelling controls.

FDA pre-market consultation and USDA inspection or label approvals are separate regulatory steps. A favourable FDA safety review alone does not necessarily permit retail sale.

FDA

 

Eat Just Granted World’s First Regulatory Approval for Cultured Meat

 

 

B. Singapore

Singapore treats cultivated meat within its novel-food safety framework. The Food Safety and Security Act 2025 formalised the requirement for pre-market approval of novel foods. The Singapore Food Agency assesses manufacturing methods, composition, toxicology, allergenicity and dietary exposure.

Approval is product-specific, and material changes to manufacturing inputs or intended use may require renewed approval.

sfa.gov.sg+1

 

EFSA’s 2025 novel food regulation changes, including stricter toxicology and allergenicity data requirements for nanomaterials and synthetic biology‑d

 

 

C. European Union

Regulation (EU) 2015/2283 on novel foods is the central framework. Cultivated meat generally requires pre-market authorisation, with scientific risk assessment involving the European Food Safety Authority (EFSA) where required.

The assessment and authorisation process examines product identity, production, composition, safety and proposed uses. Additional genetically modified food requirements may apply depending on the technology.

Wiley Online Library+1

 

Fast-track testing for lab-grown meat gets backing | The Grocer

 

 

D. United Kingdom

In Great Britain, cell-cultivated products must obtain the applicable regulated-product authorisation before being placed on the market. The Food Standards Agency and Food Standards Scotland assess safety evidence and risk-management measures.

Guidance published in 2026 explains the application route, including novel-food requirements and potential additional authorisation where genetic modification or other technologies are involved. Northern Ireland has a different relationship with EU food law.

GOV.UK+1

 

A 2025 comparative legal study identified substantial differences in regulatory discretion, public participation and the consideration of wider policy factors among the United States, Singapore, the EU, Australia and New Zealand.

Wiley Online Library

 

6. Judicial decisions and case laws

A key legal qualification is necessary: there is not yet a mature body of reported court judgments directly deciding every aspect of cultivated-meat pre-market approval. Many of the most relevant cases concern state prohibitions, constitutional limits on food regulation or labelling of alternative proteins. These cases are useful, but they should not be represented as direct judicial approval of a cultivated-meat product.

Case 1 — Upside Foods, Inc. v. Commissioner, Florida Department of Agriculture and Consumer Services (2026)

Direct cultivated-meat litigation

Court: United States Court of Appeals for the Eleventh Circuit.

Subject: Florida's statutory prohibition on cultivated meat and federal pre-emption.

Facts: Upside Foods challenged Florida's ban on the manufacture, distribution and sale of cultivated meat. The company argued, among other things, that federal poultry legislation pre-empted the state prohibition because cultivated chicken was subject to federal regulatory oversight.

Legal issue: Whether the federal Poultry Products Inspection Act (PPIA) displaced Florida's ban.

Decision: The Eleventh Circuit affirmed the denial of Upside Foods' request for a preliminary injunction, concluding that the PPIA did not pre-empt Florida's ban on the record and legal arguments before it. The court reasoned that the ban did not regulate the ingredients, premises, facilities or operations in the manner necessary for the asserted pre-emption argument to succeed.

FindLaw

 

Legal principle: Federal regulation of a food product does not necessarily prevent a state from prohibiting its sale where the federal statute does not pre-empt that prohibition.

Significance: Even when a product has passed federal safety review, separate state-law restrictions may create additional barriers to market access. The ruling concerned preliminary relief and the particular pre-emption arguments; it should not be treated as a universal ruling on all state bans or as a finding that cultivated meat is unsafe.

Case 2 — Wildtype, Inc. et al. v. Shuford et al. (2025–2026)

Court: United States District Court for the Western District of Texas.

Subject: Texas Senate Bill 261 and the constitutionality of a state-level cultivated-meat prohibition.

Facts: Cultivated-meat producers challenged Texas legislation restricting the sale of cell-cultured protein products. They raised constitutional arguments involving interstate commerce and federal pre-emption.

Legal issues:

Whether the law impermissibly burdens interstate commerce.

Whether federal food legislation pre-empts the state restriction.

Whether the challenged prohibition unlawfully discriminates against businesses operating across state lines.

Procedural position: The case involved motions to dismiss and a request for preliminary injunctive relief. The litigation raises questions distinct from the FDA's assessment of a product's scientific safety.

nationalaglawcenter.org+1

 

Significance: The case illustrates the difference between regulatory authorisation and constitutional permission to sell. Even if a producer satisfies one regulatory regime, the interaction between federal and state law may remain contested.

The allegations made by the companies are not themselves judicial findings that the Texas law is unconstitutional.

Case 3 — Turtle Island Foods, SPC v. Richardson (2026)

Court: United States District Court for the Western District of Texas.

Subject: Challenges to Texas restrictions on alternative-protein products.

The litigation raised issues concerning federal pre-emption, interstate commerce, due process and restrictions on the labelling or sale of alternative-protein products. The court's procedural rulings addressed standing and the scope of the claims, rather than establishing a general right to market cultivated meat.

FindLaw

 

Legal principle: A claimant must establish standing and satisfy the relevant procedural requirements before a court can decide the substantive constitutionality of a food-law restriction.

Relevance: Companies seeking approval or challenging restrictions should distinguish between a regulator's scientific decision, the validity of a statute and the procedural requirements for judicial review.

Case 4 — Tofurky v. Arkansas (2023)

Court: United States Court of Appeals for the Eighth Circuit.

Subject: Constitutional restrictions on labelling plant-based food products.

This litigation concerned Arkansas restrictions on terms used to describe plant-based products, rather than cultivated meat itself. The dispute illustrates how labelling legislation can implicate commercial speech and the First Amendment to the US Constitution.

Legal principle: Government restrictions on commercial labelling may be subject to constitutional scrutiny, particularly where the law restricts truthful, non-misleading information.

Relevance to cultivated meat: A government may have legitimate reasons to prevent consumers from being misled about how a product is produced. However, a labelling restriction that goes further than necessary to address consumer confusion can raise separate constitutional questions. The analysis depends on the statutory wording, the evidence of consumer confusion and the applicable constitutional standard.

This is an analogous alternative-protein labelling dispute, not a judgment granting cultivated-meat approval. For related litigation and statutory developments, see the National Agricultural Law Center's compilation.

National Agricultural Law Center

 

Case 5 — International Dairy Foods Association v. Amestoy, 92 F.3d 67 (2d Cir. 1996)

Court: United States Court of Appeals for the Second Circuit.

Subject: Mandatory labelling and commercial speech.

Facts: Vermont required dairy manufacturers to disclose whether their products came from cows treated with recombinant bovine somatotropin (rBST).

Decision: The court struck down the disclosure requirement under the First Amendment because the state had not demonstrated a sufficient justification for compelling the disclosure in the circumstances before it.

Legal principle: A government generally needs an adequate justification for compelling commercial disclosures, particularly when the requirement is not sufficiently connected to a legitimate governmental interest.

Relevance to cultivated meat: If a government requires special disclosures identifying cultivated meat, the legal analysis may examine whether the disclosure serves a legitimate consumer-information purpose and whether it is appropriately tailored.

Limitation: This case concerns dairy labelling, not cultivated-meat approval. It does not mean that all mandatory cultivated-meat disclosures are unconstitutional.

Case 6 — National Association of Manufacturers v. SEC, 800 F.3d 518 (D.C. Cir. 2015)

Court: United States Court of Appeals for the District of Columbia Circuit.

Subject: Compelled disclosures and commercial speech.

Facts: The case concerned a federal requirement that companies disclose whether their products were described as conflict-free in relation to minerals sourced from the Democratic Republic of the Congo region.

Decision: The court held that the particular compelled disclosure challenged in the case violated the First Amendment, while its analysis distinguished disclosures of purely factual, uncontroversial information from more problematic compelled statements.

Legal principle: The constitutional validity of a mandatory commercial disclosure depends on its content, context, governmental interest and the applicable free-speech standard.

Relevance: Cultivated-meat labelling rules should distinguish between factual identification of a production method and language that makes an unsupported or misleading claim about the product. This is a general constitutional analogy, not a ruling on food authorisation.

Indian judicial position

No directly controlling Indian Supreme Court or High Court judgment specifically establishing a comprehensive approval regime for cultivated meat has been identified in the sources reviewed for this answer.

Indian courts could nevertheless be asked to consider established principles of statutory authority, administrative fairness, scientific decision-making, consumer protection and constitutional review if a cultivated-meat approval or prohibition were challenged.

It would be incorrect to cite general food-safety or biotechnology cases as if they had already decided the legal status of cultivated meat in India.

7. Core legal principles emerging from the case law

The cases and regulatory frameworks support six important distinctions.

1. Regulatory competence

An authority must act within the powers granted by legislation. A regulator cannot dispense with a statutory approval merely because a product is technologically innovative.

2. Scientific risk assessment

Decisions should address relevant evidence concerning hazards, exposure, manufacturing controls and the safety of the finished product.

3. Truthful labelling

Product descriptions must not mislead consumers about ingredients, origin or production method. Mandatory additional disclosures must also comply with the applicable law.

4. Federal and state authority

In countries with multiple levels of government, the scope of federal pre-emption and state powers must be examined separately from product safety.

5. Consumer protection

Authorities may impose appropriate safeguards against misrepresentation, contamination and unsupported nutritional or health claims.

6. Judicial review

Courts may review the legality and constitutionality of restrictions, but litigation does not itself confer product authorisation.

8. Legal grounds for refusing or withdrawing approval

A regulator may refuse an application, impose conditions or withdraw an existing authorisation where the governing legislation permits it.

Common grounds include:

Insufficient safety evidence: The applicant cannot adequately establish the safety of the food.

Unacceptable microbiological or chemical risks: Manufacturing controls fail to address material contamination or residue risks.

Unresolved allergenicity: The product contains potential allergens that have not been adequately assessed or controlled.

Material manufacturing changes: A change to the cell line, growth medium or production method invalidates relevant parts of the original safety assessment.

Misleading labelling: The product's identity, composition or claims are inconsistent with the applicable legal requirements.

Failure to comply with approval conditions: The manufacturer breaches conditions governing production, distribution or intended use.

Fraud or material misrepresentation: The approval was obtained using false or misleading information.

These grounds must be applied under the relevant jurisdiction's legislation and procedural rules. For example, Singapore expressly provides for cancellation of novel-food pre-market approval in specified circumstances, including material changes, non-compliance and certain public-interest grounds.

sfa.gov.sg

 

9. Liability after approval

Regulatory approval does not give a manufacturer blanket immunity from civil, administrative or criminal liability.

Type of liabilityExample
Product liabilityA contaminated product causes injury to a consumer
NegligenceA manufacturer fails to implement reasonable contamination controls
MisbrandingThe product is marketed using an inaccurate or legally prohibited description
Contractual liabilityA supplier provides a growth medium that fails agreed specifications
Regulatory liabilityAn operator breaches an approval condition or food-safety requirement
Import liabilityA business imports or distributes a product without the required authorisation
Recall liabilityA manufacturer fails to comply with applicable withdrawal or recall duties

In India, the Food Safety and Standards Act, 2006, together with applicable regulations and other relevant laws, may provide the basis for enforcement. The specific cause of action and available remedies depend on the facts.

10. Proposed legal framework for cultivated meat approval

A well-designed statutory framework should contain the following elements.

Clear statutory definitions: Distinguish cultivated meat, plant-based substitutes, fermentation-derived ingredients and genetically modified foods where legally relevant.

Risk-based pre-market review: Require scientific evidence proportionate to the product's characteristics and foreseeable risks.

Transparent decision-making: Publish reasons for approval or refusal to the extent permitted by confidentiality and intellectual-property rules.

Defined review periods: Establish application-validation requirements, information-request procedures and appropriate decision timelines.

Manufacturing and traceability standards: Require validated processes, batch records, hygiene controls and systems for tracing products through the supply chain.

Labelling standards: Provide clear rules for product names, ingredient lists, allergen declarations and production-method claims.

Post-market surveillance: Establish complaint reporting, adverse-event investigation and recall procedures.

Review and appeal mechanisms: Allow applicants to challenge unlawful, procedurally unfair or inadequately reasoned decisions through the remedies provided by law.

11. Conclusion

Cultivated meat approval law is an emerging field at the intersection of food safety, biotechnology, administrative law, consumer protection and constitutional law.

Three conclusions are particularly important:

Scientific safety assessment and legal authorisation are distinct requirements. A favourable scientific assessment does not necessarily complete every inspection, labelling or licensing requirement.

Approval in one jurisdiction does not guarantee market access elsewhere. Domestic restrictions and separate national authorisation requirements may still apply.

Judicial review concerns legality, not merely scientific innovation. Courts examine statutory authority, constitutional limits, procedural requirements and the specific evidence and arguments presented.

For India, the Food Safety and Standards Act, 2006, and the applicable non-specified-food approval framework are central starting points. However, a prospective manufacturer should obtain confirmation from FSSAI regarding the current regulatory pathway and the product-specific approvals required before commercial sale.

Selected authoritative sources

Food Safety and Standards Authority of India — Non-Specified Food approval framework.

US Food and Drug Administration — Human food made with cultured animal cells.

Singapore Food Agency — Novel-food pre-market approval guidance.

Food Standards Agency — UK cultivated-product regulatory authorisation guidance.

Johnson, Global developments in the regulation of cultivated meat: A comparative study of the EU, Singapore, US and Australia and New Zealand (2025), comparative legal study.

Legal research note: This is a comparative educational overview, not an opinion on a specific application. Legislation, litigation and approval status can change, and case citations should be verified against official judgments before being relied on in court submissions or formal legal advice.

LawGratis provides pro bono legal aid and resources to empower communities. Join us in making justice reachable for everyone! Follow our community on Instagram, YouTube, Facebook, and LinkedIn.

LEAVE A COMMENT